Sign in Subscribe
Genetic research

Cancer Gene Therapy Advances: ViraTherapeutics GmbH Publishes New Research on Purification Process

Strategic Insights

— 1 min read

Cancer gene therapy has been an area of significant research, with companies like ViraTherapeutics GmbH working towards developing new treatments. According to a recent study, researchers at ViraTherapeutics GmbH have published a paper detailing the importance of maintaining viral integrity during the purification process of replication-competent enveloped virus particles. These particles hold significant therapeutic potential in cancer vaccines or oncolytic viruses. The study highlights the challenges posed by environmental factors on bioprocessing and emphasizes the need for high-quality standards and cost-effective production.

Key Takeaways:

  • The researchers at ViraTherapeutics GmbH identified the critical importance of maintaining viral integrity in replication-competent enveloped virus particles.
  • The study evaluated bioprocessing methods, including cell culture harvest, centrifugation, chromatographic, and filtration purification techniques, to maintain viral integrity.
  • Advanced analytical methods, such as infectious titer assays, total virus particle quantification, and structural analysis, were required to assess the impact of process steps on particles and determine their quality and integrity.
  • The researchers concluded that the insights gained from this analysis would contribute to the advancement of virus-based therapeutics, supporting the development of safe, effective, and economically viable treatments for various diseases.
  • The study emphasized the need for high-quality standards and cost-effective production in bioprocessing.
  • The researchers at ViraTherapeutics GmbH recognized the importance of maintaining viral integrity in ensuring the infectivity, safety, and efficacy of replication-competent virus particles.

Statistics:

  • The study evaluated bioprocessing methods for replication-competent enveloped virus particles, including cell culture harvest, centrifugation, chromatographic, and filtration purification techniques.
  • The researchers used advanced analytical methods, such as infectious titer assays, total virus particle quantification, and structural analysis, to determine the quality and integrity of virus particles.
  • The study aimed to contribute to the advancement of virus-based therapeutics, supporting the development of safe, effective, and economically viable treatments for various diseases.

Sources:

  • NewsRx. ViraTherapeutics GmbH Researchers Describe New Findings in Cancer Gene Therapy (Navigating the Purification Process: Maintaining the Integrity of Replication-Competent Enveloped Viruses). Vaccine Weekly. June 11, 2025; p 88.
  • (Vaccines - http://www.mdpi.com/journal/vaccines).
  • MDPI AG (publisher).
  • DOI: 10.3390/vaccines13050444 (free version at https://doi-org.sdpl.idm.oclc.org/10.3390/vaccines13050444).
  • Adrian Schimek, ViraTherapeutics GmbH, Bundesstrasse 27, 6063 Rum, Austria.
  • Judy King Man Ng, Jurgen Hubbuch (additional authors).

Read more